2022
DOI: 10.1016/j.orthop.2021.10.003
|View full text |Cite
|
Sign up to set email alerts
|

Expanding the criteria for targeted muscle reinnervation: A national assessment of eligibility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 51 publications
0
5
0
Order By: Relevance
“…Indeed, numerous studies have proved the efficacy of TMR in the prevention of PLP and neuroma formation. 11 , 13 A randomized clinical trial from 2019 demonstrated that TMR resulted in improved residual limb pain and PLP at a 1-year follow-up. 11 Additionally, in a study of 22 below-the-knee amputations, TMR yielded no patients with symptomatic neuromas at 18 months, and 13% with PLP at 6 months.…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…Indeed, numerous studies have proved the efficacy of TMR in the prevention of PLP and neuroma formation. 11 , 13 A randomized clinical trial from 2019 demonstrated that TMR resulted in improved residual limb pain and PLP at a 1-year follow-up. 11 Additionally, in a study of 22 below-the-knee amputations, TMR yielded no patients with symptomatic neuromas at 18 months, and 13% with PLP at 6 months.…”
Section: Introductionmentioning
confidence: 99%
“… 11 , 13 A randomized clinical trial from 2019 demonstrated that TMR resulted in improved residual limb pain and PLP at a 1-year follow-up. 11 Additionally, in a study of 22 below-the-knee amputations, TMR yielded no patients with symptomatic neuromas at 18 months, and 13% with PLP at 6 months. 12 TMR has also been shown to reduce postoperative opioid use.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations